Literature DB >> 27160496

Importance of left atrial pressure during ex vivo lung perfusion.

Virginia Linacre1, Marcelo Cypel2, Tiago Machuca1, Daisuke Nakajima1, Kohei Hashimoto1, Ricardo Zamel1, Manyin Chen1, Ilker Iskender1, Pedro Dos Santos1, Thomas K Waddell1, Mingyao Liu1, Shaf Keshavjee1.   

Abstract

BACKGROUND: Ex vivo lung perfusion (EVLP) allows for the evaluation and treatment of donor lungs before transplant. Different EVLP strategies have been described using either an open left atrium (LA) (pressure of 0 mm Hg) or closed LA (pressure of 5 mm Hg). We hypothesized that maintaining a physiologic positive LA pressure during EVLP is protective to the lung.
METHODS: Pig lungs were flushed with Perfadex, retrieved and stored at 4°C for 4 hours [short cold ischemic time (CIT), n = 10] or 18 hours (prolonged CIT, n = 8). Subsequently, lungs underwent normothermic EVLP for 12 hours using either an open or closed LA technique. A linear mixed effect model was used to compare functional parameters between the 2 groups.
RESULTS: After short CIT, 12-hour EVLP could not be completed in 4 of 5 open atrium cases due to significant pulmonary edema. Lung injury was evident in this group after 7 hours of EVLP, demonstrating an increase in pulmonary vascular resistance (p < 0.001) and peak inspiratory pressure (p = 0.001), and a decrease in lung compliance (p < 0.001) and perfusate oxygenation (p = 0.04). In contrast, in the closed atrium group, all lungs completed 12 hours of EVLP with stable functional parameters. At the end of the experiment, the wet/dry ratio (p = 0.015) and lung edema score (p = 0.02) were significantly worse in the open LA group compared with the closed LA EVLP group. Similar findings were observed in the prolonged CIT group.
CONCLUSION: The use of a closed atrial technique to create a controlled positive LA during EVLP leads to significantly less edema and superior lung physiology.
Copyright © 2016 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  donor lungs; ex vivo lung perfusion; left atrium pressure; lung transplantation; pulmonary edema

Mesh:

Year:  2016        PMID: 27160496     DOI: 10.1016/j.healun.2016.02.008

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  5 in total

1.  Reduced-flow ex vivo lung perfusion to rehabilitate lungs donated after circulatory death.

Authors:  Jared P Beller; Matthew R Byler; Dustin T Money; William Z Chancellor; Aimee Zhang; Yunge Zhao; Mark H Stoler; Adishesh K Narahari; Alexander Shannon; J Hunter Mehaffey; Curtis G Tribble; Victor E Laubach; Irving L Kron; Mark E Roeser
Journal:  J Heart Lung Transplant       Date:  2019-09-18       Impact factor: 10.247

2.  Prolonged EVLP Using OCS Lung: Cellular and Acellular Perfusates.

Authors:  Gabriel Loor; Brian T Howard; John R Spratt; Lars M Mattison; Angela Panoskaltsis-Mortari; Roland Z Brown; Tinen L Iles; Carolyn M Meyer; Haylie R Helms; Andrew Price; Paul A Iaizzo
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

Review 3.  Machine perfusion of thoracic organs.

Authors:  Dirk Van Raemdonck; Filip Rega; Steffen Rex; Arne Neyrinck
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

4.  Endothelial Glycocalyx Shedding Occurs during Ex Vivo Lung Perfusion: A Pilot Study.

Authors:  Timothy M Sladden; Stephanie Yerkovich; Douglas Wall; Maxine Tan; William Hunt; Jonathan Hill; Ian Smith; Peter Hopkins; Daniel C Chambers
Journal:  J Transplant       Date:  2019-08-25

5.  Multiday maintenance of extracorporeal lungs using cross-circulation with conscious swine.

Authors:  Ahmed E Hozain; Yuliya Tipograf; Meghan R Pinezich; Katherine M Cunningham; Rachel Donocoff; Dawn Queen; Kenmond Fung; Charles C Marboe; Brandon A Guenthart; John D O'Neill; Gordana Vunjak-Novakovic; Matthew Bacchetta
Journal:  J Thorac Cardiovasc Surg       Date:  2019-10-17       Impact factor: 6.439

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.